Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses

Assessing Predictors of Outcomes of Guidelines-Concordant Treatment in Women with Early Stage Breast Cancer